Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.
Also called NCT06658197
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 850 participants
- Sponsor
- Registry
-
NCT06658197
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06658197. Randomized; single masking; primary purpose treatment. Start 2025-12-25 (actual); primary completion 2026-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
- Acronym
- TNK-LVO
- Condition
- Stroke, Ischemic
- Condition
- Stroke, Acute
- Condition
- Thrombosis, Brain
- Condition
- Drug Effect
- Intervention (Drug)
- Tenecteplase
- Intervention (Drug)
- Alteplase
- Lead sponsor
- Xuanwu Hospital, Beijing
Record details
- Record id
cardio:ct-nct06658197- Content hash
baf1be5582919acf7abfa218c12a7e5fcb31bfbbff622be7473c28c4463a1f07